|This article needs additional citations for verification. (January 2017) (Learn how and when to remove this template message)|
Phytotherapy is the use of plants and plant extracts for attempted therapeutic purposes.
Phytotherapy is distinct from homeopathy and anthroposophic medicine, and avoids mixing plant and synthetic bioactive substances. Phytotherapy is regarded by some as traditional or alternative medicine. The medicinal and biological effects of many plant constituents such as the alkaloids, morphine and atropine, for example, have been proven through clinical studies.
A reference guide to phytotherapy Rationale Phytotherapy was first published in German in 1996 and this was published in English in 1997 as Rational Phytotherapy under the supervision of American pharmacognosist Varro Tyler.
In 2002, the U.S. National Center for Complementary and Integrative Health of the National Institutes of Health began funding clinical trials into the effectiveness of herbal medicine. In a 2010 survey of 1000 plants, 356 had clinical trials published evaluating their "pharmacological activities and therapeutic applications" while 12% of the plants, although available in the Western market, had "no substantial studies" of their properties.
In a review on herbal medicine in malaria treatment, the authors found that "...better evidence from randomised clinical trials is needed before herbal remedies can be recommended on a large scale. As such trials are expensive and time consuming, it is important to prioritise remedies for clinical investigation...."
In herbal medicine, plant material that has been processed in a repeatable operation so that a discrete marker constituent is at a verified concentration is then considered standardized. Active constituent concentrations may be misleading measures of potency if cofactors are not present. A further problem is that the important constituent is often unknown. For instance St John's wort is often standardized to the antiviral constituent hypericin which is now known to be the active ingredient for antidepressant use. Other companies standardize to hyperforin or both, although there may be some 24 known possible constituents. Only a minority of chemicals used as standardization markers are known to be active constituents. Standardization has not been standardized yet: different companies use different markers, or different levels of the same markers, or different methods of testing for marker compounds. The renowned herbalist and ethnobotanist David Winston points out that whenever different compounds are chosen as 'active ingredients' for different herbs, there is a chance that suppliers will get a substandard batch (low on the chemical markers) and mix it with a batch higher in the desired marker to compensate for the difference.
The quality of crude drugs or plant medicines depends upon a variety of factors, including the variability in the species of plant being used; the plant's growing conditions (i.e. soil, sun, climate); and the timing of harvest, post-harvest processing, and storage conditions. The quality of some plant drugs can judged by organoleptic factors (i.e. sensory properties such as the taste, color, odor or feel of the drug), or by administering a small dose of the drug and observing the effects. These conditions have been noted in historical herbals such as Culpepper's Complete Herbal or The Shennong or The Divine Farmer's Materia Medica.
Modern phytotherapy may use traditional methods of assessment of herbal drug quality, but more typically relies on modern processes like high-performance liquid chromatography (HPLC), (gas chromatography), UV/VIS (Ultraviolet/Visible spectrophotometry) or AA (atomic absorption spectroscopy). These are used to identify species, measure bacteriological contamination, assess potency and eventually create Certificates of Analysis for the material.
Quality should be overseen by either authorities ensuring Good Manufacturing Practices or regulatory agencies by the US FDA. In the United States one frequently sees comments that herbal medicine is unregulated, but this is not correct since the FDA and GMP regulations are in place. In Germany, the Commission E has produced a book of German legal-medical regulations which includes quality standards.
A number of herbs are thought to be likely to cause adverse effects. Furthermore, "adulteration, inappropriate formulation, or lack of understanding of plant and drug interactions have led to adverse reactions that are sometimes life threatening or lethal." Although many consumers believe that herbal medicines are safe because they are "natural", herbal medicines may interact with synthetic drugs causing toxicity to the patient, may have contamination that is a safety consideration, and herbal medicines, without proven efficacy, may be used to replace medicines that have a proven efficacy.
Ephedra has been known to have numerous side effects, including severe skin reactions, irritability, nervousness, dizziness, trembling, headache, insomnia, profuse perspiration, dehydration, itchy scalp and skin, vomiting, hyperthermia, irregular heartbeat, seizures, heart attack, stroke, or death. Ephedra has been an object of difficulty; having legitimate medical uses, illegal uses and powerful side effects. Known and used as Mormon Tea or Indian Tea, the plant contains the potent chemicals ephedrine and pseudoephedrine. Aside from being chemicals used to create methamphetamine they have direct central nervous system (CNS) stimulant effects including high blood pressure and high heart rate. These effects have led to strokes and other CNS or cardiac issues in certain people at certain dosages. In recent years, the safety of ephedra-containing dietary supplements has been questioned by the United States Food and Drug Administration (FDA), the National Center for Complementary and Integrative Health, and the medical community as a result of reports of serious side effects and ephedra-related deaths. However, when used appropriately by the correct people it is an effective decongestant, a bronchodilator for use in asthma and an adjuvant for the common cold.
Plants such as Comfrey and Petasites have specific toxicity due to hepatotoxic pyrrolizidine alkaloid content. There are other plant medicines which require caution or can interact with other medications, including St. John's wort and grapefruit.[medical citation needed]
In 1994, the U.S. Congress passed the Dietary Supplement Health and Education Act (DSHEA), regulating labeling and sales of herbs and other supplements. These products do not require substantial testing and have no assurance of safety and efficacy. With the implementation of the Current Good Manufacturing Practices for dietary supplements in 2007, all US companies importing, manufacturing or selling these products must comply with Federal Register Volume 72, Number 121, to test for identity, purity and strength of all dietary supplements including herbal products, and investigate quality deviations through a Corrective and preventive action plan. Furthermore, the United States Pharmacopeia has incorporated more quality control monographs for herbs and supplements, documents that are officially accepted testing protocols by the Food and Drug Administration. Dietary supplement ingredients that were not previously marketed in the US require a new product approval process.
Paraherbalism is a pseudoscientific study of extracts of natural origin and their use as medicines or health-promoting agents. Paraherbalism differ from plant-derived medicines in standard pharmacology because it does not isolate active compounds from a given plant. It relies on the false belief that preserving the complexity of substances from a given plant with less processing is safer and potentially more effective. It is neither. Phytochemical researcher Varro Eugene Tyler described paraherbalism as "faulty or inferior herbalism based on pseudoscience", using scientific terminology but lacking scientific evidence for safety and efficacy. Tyler listed ten fallacies that distinguished herbalism from paraherbalism, including claims: that there is a conspiracy to suppress safe and effective herbs; that herbs can not cause harm; that whole herbs are more effective than molecules isolated from the plants; herbs are superior to drugs; that the belief that the shape of the plant indicates its function is valid; that dilution of substances increases their potency (a doctrine of the pseudoscience of homeopathy); that astrological alignments are significant; that animal testing is not appropriate to indicate human effects; that anecdotal evidence is an effective means of proving a substance works; and that herbs were created by God to cure disease. Tyler suggests that none of these beliefs have any basis in fact.
Few diseases have any known effective herbal treatment. No disease has a herbal treatment known to be better than pharmaceutical treatment, mainly because herbal treatments are not rigorously tested in high-quality human studies. According to Cancer Research UK, "there is currently no strong evidence from studies in people that herbal remedies can treat, prevent or cure cancer".
|Wikimedia Commons has media related to Phytotherapy.|
- Moulay Alaoui-Jamali (2 September 2010). Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs. Springer Science & Business Media. pp. 558–. ISBN 1441900209.
- Heinrich M (30 May 2016). "Phytotherapy: medicine". Encyclopedia Britannica, London, UK.
- "Complementary and Alternative Medicine in the United States". Institute of Medicine, (US) Committee on the Use of Complementary and Alternative Medicine by the American Public; Washington (DC): National Academies Press (US). 2005. Retrieved 15 January 2017.
- Cravotto G, Boffa L, Genzini L, Garella D (February 2010). "Phytotherapeutics: an evaluation of the potential of 1000 plants". J Clin Pharm Ther. 35 (1): 11–48. doi:10.1111/j.1365-2710.2009.01096.x. PMID 20175810.
- "Traditional herbal medicines for malaria". BMJ. 329: 1156–1159. 2004. doi:10.1136/bmj.329.7475.1156. PMC . PMID 15539672.
- Alan Tillotson Growth, Maturity, Quality
- Culpeper's Complete Herbal by Nicholas Culpeper reprinted in 2003 by Kensington Arts Press
- The Divine Farmer's Materia Medica: A Translation of the Shen Nong Ben Cao (Blue Poppy's Great Masters Series) by Yang Shou-Zhong and Bob Flaws (translator) Blue Poppy 1998
- Making Sense of Commission E, review by Jonathan Treasure, 1999-2000.
- Talalay P. and Talalay P., "The Importance of Using Scientific Principles in the Development of Medicinal Agents from Plants", Academic Medicine, 2001, 76, 3, p238.
- Elvin-Lewis M (2001). "Should we be concerned about herbal remedies". Journal of Ethnopharmacology. 75 (2-3): 141–164. doi:10.1016/S0378-8741(00)00394-9. PMID 11297844.
- Ernst E (2007). "Herbal medicines: balancing benefits and risks". Novartis Found. Symp. 282: 154–67; discussion 167–72, 212–8. doi:10.1002/9780470319444.ch11. PMID 17913230.
- Ephedra information from Memorial Sloan-Kettering Cancer Center. Accessed April 11, 2007.
- Haller C, Benowitz N (2000). "Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids". N Engl J Med. 343 (25): 1833–8. doi:10.1056/NEJM200012213432502. PMID 11117974.
- Bent S, Tiedt T, Odden M, Shlipak M (2003). "The relative safety of ephedra compared with other herbal products". Ann Intern Med. 138 (6): 468–71. doi:10.7326/0003-4819-138-6-200303180-00010. PMID 12639079.
- "National Center for Complementary and Integrative Health Consumer Advisory on ephedra". 2004-10-01. Retrieved 2007-02-13.
- "Food and Drug Administration summary of actions regarding sale of ephedra supplements". Retrieved 2007-02-13.
- Hiller K, Loew D. 2009. Symphyti radix. In Teedrogen und Phytopharmaka, WichtlM (ed). Wissenschaftliche Verlagsgesellschaft mbH Stuttgart: Stuttgart; 644–646.
- Benedek, B.; Ziegler, A.; Ottersbach, P. (2010). "Absence of mutagenic effects of a particular Symphytum officinale L. liquid extract in the bacterial reverse mutation assay". Phytotherapy Research. 24: 466–468. doi:10.1002/ptr.3000.
- Mattocks AR 1986. Chemistry and Toxicology of Pyrrolizidine Alkaloids, Academic Press: London; 391.
- Cordell, G. A.; Quinn-Beattie, M. L.; Farnsworth, N. R. (2001). "The potential of alkaloids in drug discovery". Phytotherapy Research. 15: 183–205. doi:10.1002/ptr.890.
- "Archived copy" (PDF). Archived from the original (PDF) on 2007-09-27. Retrieved 2007-09-24. Winston, David. Herbal Medicine Introduction
- "Current Good Manufacturing Practices (CGMPs) for Dietary Supplements". Silver Spring, Maryland: U.S. Food and Drug Administration. 10 August 2015. Retrieved 19 January 2017.
- "False Tenets of Paraherbalism". www.quackwatch.org. Retrieved 2016-10-29.
- Tyler, VE; Robbers JE (1999). Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. Routledge. pp. 6–8. ISBN 0789001594.
- "Herbal medicine". Cancer Research UK. 2 February 2015. Retrieved 15 January 2017.